GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_18700/2025

Pfizer Europe MA EEIG, Pfizer Manufacturing Belgium S.A, Pfizer Ltd, Pfizer Service Company S.R.L., Pfizer B.V., Pfizer Inc, Pfizer S.A, Pfizer Pharma GmbH

Datum
2025-04-22
Kammer
Milan (IT) Central Division- Section
Verfahrensart
Application Rop 265
Sprache
EN

Metadaten

Fall-IDORD_18700-2025-9e560bba1a1d
Aktenzeichen
RegisterzeichenORD_18700/2025
EntscheidungsreferenzORD_18700/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

1 Milan - Central Division - First Instance - central division UPC_CFI_476/2024 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 22/04/2025 Claimants Pfizer Inc. Pfizer Europe MA EEIG Pfizer B.V. Pfizer S.A. Pfizer Manufacturing Belgium S.A. Pfizer Service Company S.R.L. Pfizer Pharma GmbH Pfizer Limited Counterclaimants Pfizer Corporation Austria GmbH Pfizer Aps Pfizer Oy Pfizer SAS Pfizer S.R.L. Laboratórios Pfizer, Lda Pfizer AB Pfizer Luxembourg S.A.R.L. Represented by Gareth Williams Defendant GlaxoSmithKline Biologicals SA Represented by Oliver Jan Juengst and Dr. Daniela Kinkeldey PATENT AT ISSUE 2 Patent no. Proprietor/s EP4183412 GlaxoSmithKline Biologicals S.A. DECIDING JUDGE: Full panel COMPOSITION OF PANEL – FULL PANEL Presiding judge And ...